Comparison of mid-term clinical outcome in heart transplantation patients using mycophenolate mofetil vs. enteric-coated mycophenolate sodium

BACKGROUND: Mycophenolate mofetil (MMF) is a prodrug of mycophenolic acid (MPA) and a key immunosuppressant for improving graft survival in patients with heart transplantation (HTx). However, dose reduction or interruption is occasionally needed due to gastrointestinal (GI) side effects. Enteric-coa...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Kina, Kim, Darae, Choi, Jin-Oh, Cho, Yang Hyun, Sung, Kiick, Oh, Jaewon, Cho, Hyun Jai, Jung, Sung-Ho, Lee, Hae-Young, Park, Jin Joo, Choi, Dong-Ju, Kang, Seok-Min, Kim, Jae-Joong, Jeon, Eun-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448250/
https://www.ncbi.nlm.nih.gov/pubmed/36082128
http://dx.doi.org/10.3389/fcvm.2022.957299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448250/
https://www.ncbi.nlm.nih.gov/pubmed/36082128
http://dx.doi.org/10.3389/fcvm.2022.957299

Ejemplares similares